Clinical trials sponsored by Xuanwu Hospital, Beijing

Phase breakdown

Conditions studied

Recruiting trials led by Xuanwu Hospital, Beijing

• AV133 Longitudinal Imaging Study in Patients With Early and Prdromal Parkinson's Disease
  NCT06456684 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female) · 1 location
• Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
  NCT07087873 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Biomarker-Integrated Digital Guidance for Early Alzheimer's Detection (BRIDGE-AD): A Nationwide Multicenter Study
  NCT07284264 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · 6 locations
• Biomarker-based Alzheimer's Disease Cohort Study (BASIC)
  NCT07109999 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Clinical Analgesic Management in Dementia
  NCT07323914 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · 1 location
• Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
  NCT06092125 · Phase: Not specified · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Constant Current Versus Constant Voltage Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease
  NCT06742450 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Effect of MIT for CI With Anxiety
  NCT06969053 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years and older · Sex: All (male and female) · 1 location
• Effect of WBT for CI With Depression
  NCT06968013 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years and older · Sex: All (male and female) · 1 location
• Effectiveness of Personalized Alternating Current Stimulation for Treating Cognitive Impairment in CNS Demyelination Patients
  NCT06968039 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Effects and Mechanisms of Temporal Interference Brain Stimulation on Memory Function in Preclinical Alzheimer's Disease
  NCT07031687 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 80 Years · Sex: All (male and female) · 2 locations
• Effects of Tai Chi on Chronic Insomnia Disorder Combined With Hyperarousal/Anxiety
  NCT06967974 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Evaluating Modulation Effects of Burst Stimulation Patterns Using SEEG
  NCT06667232 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 65 Years · Sex: All (male and female) · 1 location
• Evaluating Modulation Effects of Temporal Interference Using SEEG
  NCT06663969 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 65 Years · Sex: All (male and female) · 1 location
• Investigating the Functional Characteristics During Wakefulness and Sleep Based on SEEG
  NCT06524479 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 65 Years · Sex: All (male and female) · 1 location
• Investigator Initiated Trial of Galcanezumab Treatment in Alzheimer's Disease
  NCT07323927 · Phase: Early Phase 1 · Ages: 50 Years to 90 Years · Sex: All (male and female) · 1 location
• Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease
  NCT06992804 · Phase: Early Phase 1 · Ages: 50 Years to 90 Years · Sex: All (male and female) · 1 location
• Neural Mechanisms and Clinical Applications of DBS for Modulating Sleep Dysregulation in PD
  NCT06914466 · Phase: Not specified · Ages: 19 Years to 80 Years · Sex: All (male and female) · 1 location
• RNS for Treatment-resistant Obsessive-compulsive Disorder
  NCT06782867 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease
  NCT05901818 · Phase: Phase 1 · Ages: 30 Years to 85 Years · Sex: All (male and female) · 1 location
• Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)
  NCT06719791 · Phase: Early Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Study on the Health Economic Burden of Alzheimer's Disease in China
  NCT05995418 · Phase: Not specified · Ages: 40 Years to 100 Years · Sex: All (male and female) · 1 location
• Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy
  NCT06248333 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 65 Years · Sex: All (male and female) · 1 location
• Temporal Interference for Drug Resistant Epilepsy
  NCT06708143 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years to 60 Years · Sex: All (male and female) · 1 location
• The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease
  NCT07457125 · Phase: Phase 1, Phase 2 · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy
  NCT07095933 · Phase: Early Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Xuanwu Hospital, Beijing recruiting for?

Xuanwu Hospital, Beijing is the lead sponsor of 26 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.